Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer

Por Bokemeyer, C, Oechsle, K, Hartmann, J T, Schöffski, P, Schleucher, N, Metzner, B, Schleicher, J, Kanz, L
Publicado em 2002

First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation

Por Wilhelm, M, Smetak, M, Reimer, P, Geissinger, E, Ruediger, T, Metzner, B, Schmitz, N, Engert, A, Schaefer-Eckart, K, Birkmann, J
Publicado no Blood Cancer J (2016)

First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial

Por Bokemeyer, C, Schleucher, N, Metzner, B, Thomas, M, Rick, O, Schmoll, H-J, Kollmannsberger, C, Boehlke, I, Kanz, L, Hartmann, J T
Publicado em 2003

IL-2 in combination with IFN-αand 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial

Por Atzpodien, J, Kirchner, H, Illiger, H J, Metzner, B, Ukena, D, Schott, H, Funke, P J, Gramatzki, M, Jürgenson, S von, Wandert, T, Patzelt, T, Reitz, M
Publicado em 2001

Interleukin-2/interferon-α2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal...

Por Atzpodien, J, Kirchner, H, Rebmann, U, Soder, M, Gertenbach, U, Siebels, M, Roigas, J, Raschke, R, Salm, S, Schwindl, B, Müller, S C, Hauser, S, Leiber, C, Huland, E, Heinzer, H, Siemer, S, Metzner, B, Heynemann, H, Fornara, P, Reitz, M
Publicado em 2006